Contineum Therapeutics has become the latest biotech to file for an initial public offering (IPO) in the US, hoping to raise $150 million for its early clinical-stage candidate for progressive ...
Complete Microsoft Corp. stock information by Barron's. View real-time MSFT stock price and news, along with industry-best analysis.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results